arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Sunday 10 March

Sunday 10 Mar

Session 1: Challenges in screen detected early cancers

08:15

Prediction models for lymph node metastasis

Miangele Lacle, the Netherlands

08:35

Evaluation of the resection margin- is 1 mm sufficient?

Maurice Laughry, Ireland

08:55

What is coming next in the prediction of LNM-

Cord Langner, Austria

09:15

Discussion

Session 2: What’s new in diagnostic imaging – and what are the therapeutic consequences?

09:30

Locoregional staging of colon and rectal cancer

Regina Beets-Tan, the Netherlands

09:50

Imaging modalities for liver metastases

Doenja Lambregts, the Netherlands

10:10

New diagnostic tools: radiomics, “deep learning” – really helpful?

T.b.a.

10:30

Discussion

10:30

until 16:30 hrs. // Parallel program – Gastroenterology

Select the menu scientific program >> Sunday 10 March parallel program – Gastroenterology for more information about the programme.

10:45

Break

Session 3: State of the art and development in neo-adjuvant treatment

11:15

Difference between cCR after CRT for advanced rectal cancer and aiming for cCR with CRT in early rectal cancer

Rob Glynne-Jones, United Kingdom

11:35

Is chemotherapy going to replace radiotherapy in rectal cancer?

David Sebag Montefiore, United Kingdom

11:55

Deciding on further local treatment after induction therapy for local and metastatic disease; value and timing of re-staging modalities

Geerard Beets, the Netherlands

12:15

Discussion

12:30

Lunch & Poster viewing

CRC Group Meetings / Trial Meetings / Consensus or Guideline initiatives

12:45

InterAACT: A global initiative in anal cancer

Sheela Rao, United Kingdom

12:45

Presentation of CIREL and CIEMAR registries

Philippe Pereira, Germany

12:45

Translational research: from bench to bedside and back

Onno Kranenburg, the Netherlands (more information about the program, please expand the menu)

12:45 From Tissue towards Liquid biopsy: current status
Marc Peeters, Belgium
13:00 The serrated pathway: implications for research
Iris Nagtegaal, the Netherlands
13:15 Translational research: from bench to bedside and back
Onno Kranenburg, the Netherlands
13:30 Selected abstract to be announced

Session 4: Case discussion with expert panel

Session 5: Translational research: From markers to decisions

15:00

Clinical implications of “liquid” markers (ctDNA) for treatment selection and response evaluation

Karen-Lise Spindler, Denmark

15:20

Clinical implications of tissue-based markers (CMS and others)

Louis Vermeulen, the Netherlands

15:40

Organoids to assess treatment response

Nicola Valeri, United Kingdom

16:00

Break

Session 6: What’s new in diagnostic and therapeutic endoscopy?

16:30

State of the art optical diagnosis of polyps

Jara Backes, the Netherlands

16:50

Endoscopic and surgical techniques for local excision in rectal cancer, what should we do?

T.b.a.

17:10

Endoscopic and hybrid techniques for local excision of colon cancer

Leon Moons, the Netherlands

17:30

Discussion

19:00

Dinner event